Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

BPMC

Live52w high -0.1%

Log in Get Started

52w high -0.1%

FINRA-reported short interest data for BPMC, plus the related observational metrics traders commonly track (days to cover, short float, trend). Stonvex makes no prediction and provides no recommendation — this page is a data summary, not investment advice.

Short float

—

Short interest ÷ shares outstanding

Days to cover

1.0

At trailing 90-day avg volume

SI vs prior

-54.7%

Change since last FINRA settlement

Price · 30 days

—

Trailing close-to-close move

Short interest

1.67M

As of 2025-07-15

Avg daily volume

3.51M

Trailing 90 days · FINRA

Last close

$129.46

Vol 2.98M

Short interest trend · last 6 reports

↓2025-07-151.67M-54.7%

↑2025-06-303.68M+17.6%

↓2025-06-133.13M-48.6%

↑2025-05-306.08M+7.4%

→2025-05-155.67M+0.2%

→2025-04-305.66M+1.7%

FINRA settles short interest twice a month. An ↑ arrow means shorts were adding into the position vs the prior settlement (crowding); a ↓ arrow means shorts were covering.

Why the latest row isn't today's date: FINRA collects short-interest snapshots on the 15th and last business day of each month, then publishes them ~8 business days later. The newest published row above (2025-07-15) is the most current FINRA data in existence. Next expected update: Aug 12, 2025 (for the 2025-07-31 settlement).

Next earnings date

No upcoming earnings date in Finnhub's calendar for BPMC. ETFs, foreign issuers, and recently-listed tickers are commonly missing here.

Same-sector peers

TickerPrice30dActivity

Intellia Therapeutics

$13.67+0.0%60

MRNA

Disclaimer: All figures on this page are publicly reported data points (FINRA short interest, exchange-listed options, scheduled earnings dates). Stonvex does not classify securities as buys, sells, holds, squeezes, or any other directional label. Nothing here is investment advice or a recommendation. Stonvex is not a registered investment advisor.

Moderna

$49.04

+0.0%

60

Click a peer to view its short-interest data.